Skip to main content

Dalton Pharma to Use Thermo Fisher Tech for Biopolymers

NEW YORK (GenomeWeb News) – Dalton Pharma Services will use Thermo Fisher Scientific’s enzyme-based technology to make nucleic acid biopolymers for use in drug development research projects, Toronto-base Dalton said today.
 
Dalton will produce poly-inosine and poly-cytosine in accordance with current good manufacturing practice regulations.
 
These polynucleotides are used as catalysts to stimulate immune responses when they are combined with other substances in a drug, the company said.
 
Dalton also said it plans to supply these polynucleotides to the pharmaceutical company Oncovir, which will use them in vaccine development projects.
 
Financial terms of the agreement were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.